Assessment of Nitrosamine Impurities in Lurasidone Hydrochloride Using APCI‐LC–MS/MS in MRM Mode for Regulatory Compliance and Stability Evaluation
Rapid Communications in Mass Spectrometry · 2025
DOI: 10.1002/rcm.10126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, 2025. Verfasst von Anant D Yadav und 4 weiteren Autor:innen. Beteiligte Einrichtung: Tarsadia Institute of Chemical Science, Uka Tarsadia University, Bardoli, Gujarat, India. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Lurasidone Hydrochloride, Nitrosamines, Drug Contamination. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Rationale
Nitrosamine impurities, such as N‐nitroso diethylamine (NDEA), N‐nitroso dimethylamine (NDMA), and 1‐nitroso piperazine (1‐NP), have raised serious health concerns due to their carcinogenic and mutagenic properties. The pharmaceutical industry faces increasing regulatory pressure to monitor these compounds at trace levels. This study addresses the need for a robust analytical method to ensure the safety of lurasidone hydrochloride (LUR), an antipsychotic drug.
Methods
A sensitive and specific LC–MS/MS method was developed using atmospheric pressure chemical ionization (APCI) in positive mode and operated in multiple reaction monitoring (MRM). Chromatographic separation was performed on a Sapphirus C18 HP‐classic column under gradient elution, with 0.1% formic acid in water and methanol as the mobile phase. Detection was carried out using an Agilent 6470B triple‐quadrupole mass spectrometer.
Results
The method demonstrated excellent linearity (regression coefficient > 0.999) across a range extending to 200% of the specified limit. Limits of detection and quantitation were suitable for trace‐level analysis. Accuracy was confirmed through recovery studies, with results ranging between 80 and 120%. The method met ICH Q2 (R2) validation criteria, ensuring reliability for regulatory use.
Conclusions
The developed APCI‐LC–MS/MS method provides accurate and reproducible quantification of NDEA, NDMA, and 1‐NP in lurasidone hydrochloride. Its sensitivity and compliance with regulatory standards make it suitable for routine quality control and stability testing of nitrosamine impurities in lurasidone hydrochloride drug substance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tarsadia Institute of Chemical Science, Uka Tarsadia University, Bardoli, Gujarat, India.
- Analytical Research and Development, Alkem Laboratories Ltd., Bharuch, Gujarat, India.
- Maliba Pharmacy College, Uka Tarsadia University, Maliba Campus, Bardoli, Gujarat, India.
ORCID-Profile: Anil H Gore
Zitieren
APA
Yadav, A. D., Alaspure, A. C., Bhavsar, P. S., Lodha, S. R., & Gore, A. H. (2025). Assessment of Nitrosamine Impurities in Lurasidone Hydrochloride Using APCI‐LC–MS/MS in MRM Mode for Regulatory Compliance and Stability Evaluation. Rapid Communications in Mass Spectrometry. https://doi.org/10.1002/rcm.10126
Vancouver
Yadav AD, Alaspure AC, Bhavsar PS, Lodha SR, Gore AH. Assessment of Nitrosamine Impurities in Lurasidone Hydrochloride Using APCI‐LC–MS/MS in MRM Mode for Regulatory Compliance and Stability Evaluation. Rapid Communications in Mass Spectrometry. 2025. doi:10.1002/rcm.10126
BibTeX
@article{Yadav2025,
author = {Yadav, Anant D and Alaspure, Ashish C and Bhavsar, Pinal S and Lodha, Sandesh R and Gore, Anil H},
title = {Assessment of Nitrosamine Impurities in Lurasidone Hydrochloride Using APCI‐LC–MS/MS in MRM Mode for Regulatory Compliance and Stability Evaluation},
journal = {Rapid Communications in Mass Spectrometry},
year = {2025},
doi = {10.1002/rcm.10126}
}
EUVIMED